Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD
New York State Psychiatric Institute
Chart Review of Patients Undergoing Ketamine Infusions
Brain and Cognition Discovery Foundation
Ketamine Infusion for Obsessive-Compulsive Disorder
Yale University
Psilocybin for Treatment of OCD-2
Francisco A Moreno
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Stanford University
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Centre for Addiction and Mental Health
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Pilot Study of RR-HNK in OCD
Carolyn Rodriguez
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
Mclean Hospital
Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)
New York State Psychiatric Institute
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Medical University of Gdansk
Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
New York State Psychiatric Institute
Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
Psyrin Inc.
Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder
New York State Psychiatric Institute
University of Iowa Interventional Psychiatry Service Patient Registry
Mark Niciu
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Neuronetics
Understanding How Ketamine Brings About Rapid Improvement in OCD
Stanford University
Open-Label Psilocybin Study in Transdiagnostic Population
Yale University
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
Carolyn Rodriguez
Effects of Psilocybin in Obsessive Compulsive Disorder
Johns Hopkins University
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Yale University
Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)
New York State Psychiatric Institute
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Francisco A Moreno
PsilOCD: A Pharmacological-Challenge Feasibility Study
Imperial College London
Psilocybin for Treatment of Obsessive Compulsive Disorder
University of Arizona
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
Wayne Goodman MD
Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD
Beersheva Mental Health Center
Effects of Repeated Psilocybin Dosing in OCD
Yale University
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
Medical University of Vienna
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
Read the trial details, eligibility criteria, and what participation involves.
Reach out to the study team using the contact information provided.
Complete the screening process to determine if you're eligible.